Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FY9CZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,824
Award facts
- Contract value 100% obligated
- $62,824.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $62,824.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of CIMZIA 2x200 mg/mL syringe kits. The contract is unclassified as a set-aside and was executed on August 8, 2025, with an ultimate completion date of August 11, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications, medical supplies, and specialized healthcare commodities to military healthcare programs globally.
CIMZIA is a specialty pharmaceutical used to treat inflammatory conditions and represents the type of specialized medical product within AmerisourceBergen's extensive federal portfolio. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated capability to meet DLA requirements through competitive procurement processes. The DLA Troop Support Medical contract vehicle serves as the funding mechanism supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the agency planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts across multiple regions in the coming years.
Quick answers
Who was awarded contract SPE2DB25FY9CZ?
SPE2DB25FY9CZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FY9CZ worth?
The government has obligated $62,824 on SPE2DB25FY9CZ.
Is contract SPE2DB25FY9CZ an order under another contract?
Yes. SPE2DB25FY9CZ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9CZ competed?
The extent of competition for SPE2DB25FY9CZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award